Pharmacological aspects of peripheral noradrenergic transmission.
D000313:Adrenal Medulla / Q000032:analysis; D000818:Animals; D001369:Axons / Q000032:analysis; D002417:Cattle; D002499:Centrifugation, Density Gradient; D002838:Chromaffin System / Q000032:analysis / Q000201:enzymology; D004285:Dogs; D004299:Dopamine beta-Hydroxylase / Q000032:analysis / Q000097:blood / Q000378:metabolism; D005725:Ganglia, Autonomic / Q000032:analysis / Q000378:metabolism; D009411:Nerve Endings / Q000032:analysis; D009419:Nerve Tissue Proteins / Q000032:analysis; D009638:Norepinephrine / Q000032:analysis / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D013153:Splanchnic Nerves / Q000032:analysis; D013154:Spleen / Q000201:enzymology / Q000294:innervation / Q000378:metabolism; D013564:Sympathetic Nervous System / Q000378:metabolism*; D009435:Synaptic Transmission; D014316:Tritium
D009419:Nerve Tissue Proteins; D014316:Tritium; D004299:Dopamine beta-Hydroxylase; D009638:Norepinephrine